Skip to main content
. 2025 Apr 9;17(4):501. doi: 10.3390/pharmaceutics17040501
ACNPs Antibody-conjugated nanoparticles
AP-NLC ARV-825-loaded PEGylated NLCs
API Active pharmaceutical ingredient
AR Androgen receptor
ARV-SNEP ARV-825-loaded self-nanoemulsifying preconcentrate
ASDs Amorphous solid dispersion
BBB Blood–brain barrier
CME Camel milk-derived exosome
CRBN Cereblon
DS-PLGA Disulfide-linked poly (lactic-co-glycolic acid)
EPR Enhanced permeability and retention
ER Estrogen receptor
GALARV Galactose-decorated nanoliposomal formulation
GSH Glutathione
HCC Hepatocellular carcinoma
LLCM Lung cancer cell membrane
LNP Lipid nanoparticles
MPRO Folate-PEG-PROTAC micelles
MSPM Mixed-shell polymeric micelle
MZ1-NPs MZ1-loaded polymeric nanoparticles
nChap Nanochaperone-based
NLC Nanostructured lipid carrier
NSCLC Non-small cell lung cancer
PCL Polycaprolactone
PDSA Poly(disulfide amide)
PEG Polyethylene glycol
PEI Polyethyleneimine
PEO-PPO-PEO Poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide)
PGDAT Self-assembling PROTAC nanoparticle
PLA Polylactide
PLGA Poly(lactic-co-glycolic acid)
POI Protein of interest
PROTAC Proteolysis targeting chimeras
PVA Polyvinyl alcohol
PVP Polyvinylpyrrolidone
RCNprotac X-ray radiation responsive PROTAC nanomicelle
ROS Reactive oxygen species
SNEDDS Self-nanoemulsifying drug delivery system
SP Substance P
TAMs Tumor-associated macrophages
TNBC Triple-negative breast cancer
UPS Ubiquitin–proteosome system
VHL Von Hippel–Lindau